Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Journal of Clinical Gastroenterology|November 24, 2020
WGO Guidance for the Care of Patients With COVID-19 and Liver DiseaseSaeed Hamid, Mario R Alvares da Silva, Kelly W Burak, et al.
Journal of Hepatology|July 19, 2011
Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantationIngmar Mederacke, Natalie Filmann, Cihan Yurdaydin, et al.
Journal of Hepatology|September 9, 2014
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovirGeorge V Papatheodoridis, George N Dalekos, Cihan Yurdaydin, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Management of hepatitis C virus infection in the Asia-Pacific region: an updateSeng Gee Lim, Alessio Aghemo, Pei-Jer Chen, et al.
Journal of Viral Hepatitis|November 13, 2020
A transient early HBV-DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV-RNA and HBsAg reductionOlympia E Anastasiou, Cihan Yurdaydin, Benjamin Maasoumy, et al.
Scientific Reports|July 2, 2025
Investigating hepatic fibrosis heterogeneity by three-dimensional imaging in metabolic dysfunction-associated steatotic liver diseaseBuket Yigit, Ekin Ozgonul, Omer Yaman, et al.
Journal of Hepatology|December 19, 2015
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapyGeorge Papatheodoridis, George Dalekos, Vana Sypsa, et al.
The Lancet. Infectious Diseases|July 21, 2015
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trialChristopher Koh, Laetitia Canini, Harel Dahari, et al.
Cell Reports. Medicine|January 31, 2025
Integrative proteo-transcriptomic characterization of advanced fibrosis in chronic liver disease across etiologiesHong Yang, Dila Atak, Meng Yuan, et al.
Journal of Hepatology|August 23, 2016
Tenofovir disoproxil fumarate (TDF) vs. emtricitabine (FTC)/TDF in lamivudine resistant hepatitis B: A 5-year randomised studyScott Fung, Peter Kwan, Milotka Fabri, et al.
Pageof 12